The Effect of High-Intensity Interval Training on Maximum Walking Distance and Functional Parameters in Patients With Multiple Sclerosis at Different Disability Levels

RecruitingNot a drug-phase studyMS (type not specified)NCT07771868

What it found

Still running

No result yet.

What was tested

Treatment tested

  • High-Intensity Interval Training

What it measured

Main measures

  • Maximum Walking Distance

    Assessed at baseline (pre-intervention), immediately post-intervention (at 8 weeks), and 4 weeks post-intervention (follow-up)

    Walking and mobility

Other measures (7)

  • Fatigue

    Baseline, immediately post-intervention, and 4 weeks follow-up

    Fatigue
  • Muscle Strength

    Baseline, immediately post-intervention, and 4 weeks follow-up

    Physical function
  • Muscular Endurance

    Baseline, immediately post-intervention, and 4 weeks follow-up

  • Gait Speed

    Baseline, immediately post-intervention, and 4 weeks follow-up

    Walking and mobility
  • Health-Related Quality of Life

    Baseline, immediately post-intervention, and 4 weeks follow-up

    Quality of life (reported by participants)
  • balance

    Baseline, immediately post-intervention, and 4 weeks follow-up

    Walking and mobility
  • Dynamic Balance

    Baseline, immediately post-intervention, and 4 weeks follow-up

    Walking and mobility

Who could take part

MS (type not specified) · 18 to 65 · EDSS 0 to 6.5

Show the full criteria

Inclusion criteria

* Be between the ages of 18 and 65, * Have been diagnosed with MS by a treating physician, * Have an EDSS score between 0 and 6.5, * Not having experienced a relapse within the last 3 months, * Not having severe lower extremity contractures, severe spasticity (≥3 on the Modified Ashworth Scale), or an acute orthopedic problem that would prevent the participant from pedaling on a bicycle ergometer, * Having a Mini Mental State Examination score of ≥24.

Exclusion criteria

* Having a severe cardiovascular, orthopedic, respiratory, or metabolic disease, * Having an additional neurological condition, * Being pregnant or suspecting pregnancy, * Having received a botulinum toxin injection within the last 3 months, * Having a COMPASS-31 total score greater than 13.6

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

Multiple Sclerosis (MS) is a chronic neurological disease that can affect daily functioning, mobility, and overall quality of life. High-Intensity Interval Training (HIIT) is known to be a time-efficient exercise approach that improves exercise capacity and reduces fatigue in MS. However, current research lacks sufficient data on how HIIT affects individuals with different levels of disability. The main purpose of this study is to evaluate the effects of a stationary bicycle-based HIIT protocol on maximum walking distance, fatigue, balance, muscle strength, endurance, gait speed, and quality of life in MS patients across three different disability levels: mild, moderate, and severe (classified according to Expanded Disability Status Scale - EDSS scores). Participants will complete a cycle ergometer-based HIIT program. Assessments will be conducted at three time points: Before starting the exercise program (baseline) Immediately after completing the program (post-treatment) 4 weeks after the completion of the program (follow-up) To ensure unbiased results, a triple-blind design will be used, meaning the outcome assessor, the treating physiotherapist, and the data analyst will be blinded to group assignments. The findings aim to help clinicians tailor personalized, effective HIIT protocols based on a patient's specific disability level rather than using a standardized, one-size-fits-all approach in MS rehabilitation.

Loading reviews and guidelines…

History

    1. Started

      Sept 2026

    2. Main results due

      Dec 2027

    3. Finished

      Jan 2028

    Assembled by software from public sources.